Bio Rad Laboratories Stock Last Dividend Paid
| BIO-B Stock | USD 336.00 3.36 0.99% |
Bio Rad Laboratories fundamentals help investors to digest information that contributes to Bio Rad's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Rad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Rad stock.
Bio | Last Dividend Paid |
Bio Rad Laboratories Company Last Dividend Paid Analysis
Bio Rad's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Bio Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for Bio Rad is extremely important. It helps to project a fair market value of Bio Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Bio Rad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio Rad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio Rad's interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBio Dividends Paid
Dividends Paid |
|
Based on the recorded statements, Bio Rad Laboratories has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Bio Fundamentals
| Return On Equity | -0.0979 | ||||
| Return On Asset | 0.0186 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 9.28 B | ||||
| Shares Outstanding | 5.07 M | ||||
| Shares Owned By Insiders | 97.96 % | ||||
| Shares Owned By Institutions | 0.08 % | ||||
| Number Of Shares Shorted | 3 | ||||
| Price To Earning | 17.05 X | ||||
| Price To Book | 1.26 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 2.67 B | ||||
| Gross Profit | 1.57 B | ||||
| EBITDA | (608.26 M) | ||||
| Net Income | (637.32 M) | ||||
| Cash And Equivalents | 858.99 M | ||||
| Cash Per Share | 28.81 X | ||||
| Total Debt | 1.41 B | ||||
| Debt To Equity | 13.90 % | ||||
| Current Ratio | 4.57 X | ||||
| Book Value Per Share | 267.46 X | ||||
| Cash Flow From Operations | 374.94 M | ||||
| Short Ratio | 0.20 X | ||||
| Earnings Per Share | (28.09) X | ||||
| Price To Earnings To Growth | 1.21 X | ||||
| Number Of Employees | 7.7 K | ||||
| Beta | 0.94 | ||||
| Market Capitalization | 1.71 B | ||||
| Total Asset | 12.3 B | ||||
| Retained Earnings | 9.26 B | ||||
| Working Capital | 2.53 B | ||||
| Net Asset | 12.3 B |
About Bio Rad Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Rad Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.